These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 4971831)

  • 1. [Cytologic and cytogenetic studies on the experimental medullary lesions of daunomycin].
    Marinone G; Robustelli della Cuna G; Marini G
    Haematologica; 1967; 52(7):503-30. PubMed ID: 4971831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chromosome damage by daunomycin. In vivo evaluation of the damaging dose-effect ratio].
    Robustelli della Cuna G; Pollini G; Bisldi GP
    Haematologica; 1969; 54(7):483-92. PubMed ID: 4986883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytologic and cytogenetic aspects of the anticellular effect of 2-3-5-tris-ethyleneiminobenzoquinone (TEIB) in vivo and in vitro].
    Robustelli Della Cuna G; Marini G; Maggi G
    Haematologica; 1968; 53(8):609-26. PubMed ID: 4975322
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of acute granulocytic leukoses with daunomycin: 14 cases].
    Giralt M; Torres A; Raichs A
    Sangre (Barc); 1969; 14(3):309-17. PubMed ID: 5288843
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicology of daunorubicin in animals and man.
    Maral RJ; Jouanne M
    Cancer Treat Rep; 1981; 65 Suppl 4():9-18. PubMed ID: 6809317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic effects of rubidomycin (or daunomycin)].
    De Grouchy J; De Nava C
    Ann Genet; 1968 Mar; 11(1):39-44. PubMed ID: 5301754
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytogenetic contribution to clinical and cytologic diagnosis].
    Nespolo A; Bonadonna G; Caprio G
    Haematol Lat; 1966; 9(4):304-9. PubMed ID: 5242154
    [No Abstract]   [Full Text] [Related]  

  • 8. [First experimental studies on the cytologic action in vivo of a new antibiotic with anticellular activity, the alanosine].
    Marinone G; Robustelli della Cuna G; Marini G
    Haematologica; 1967; 52(11):871-93. PubMed ID: 4975736
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytogenetic studies on rat leukemia induced by pulse doses of 7,12-dimethylbenz(alpha)anthracene.
    Kurita Y; Sugiyama T; Nishizuka Y
    Cancer Res; 1968 Sep; 28(9):1738-52. PubMed ID: 5676732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rubidomycin-daunomycin therapy in acute myeloblastic leukemia].
    Dano K; Nissen NI; Pedersen-Bjergaard J; Thiede T
    Nord Med; 1968 Oct; 80(44):1475-82. PubMed ID: 5247180
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of hemopoiesis inhibition and recovery after the administration of carminomycin and rubomycin in an experiment].
    Novitskiĭ VV; Pichugina TV; Gol'dberg ED
    Antibiotiki; 1984 Jun; 29(6):437-41. PubMed ID: 6476806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated daunomycin administration in rats. Pharmacokinetics and bone marrow toxicity.
    Nooter K; Sonneveld P; Deurloo J; Oostrum R; Schultz F; Martens A; Hagenbeek A
    Cancer Chemother Pharmacol; 1984; 12(3):187-9. PubMed ID: 6705136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative impulsecytophotometric and morphological studies of the bone marrow of the rat after daunomycin (author's transl)].
    Wehbe S; Düllmann J; Linden WA; Reddy SB; Brückner V
    Res Exp Med (Berl); 1974; 162(1):67-74. PubMed ID: 4810841
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
    Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
    Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors responsible for increasing the cytogenetic effectiveness of cyclophosphamide administered to irradiated animals. Cytogenetic effect of mutagens not requiring metabolic activation on bone marrow cells of irradiated rats].
    Iakovleva TK; Barkan RS
    Radiobiologiia; 1983; 23(4):536-8. PubMed ID: 6611883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical usefulness of eticholanolone in the evaluation of bone marrow reserves in patients treated with myelosuppressive drugs and with radiotherapy].
    Marcolongo R; Di Paolo N; Bianco G; Bravi A
    Haematologica; 1969; 54(9):603-26. PubMed ID: 4994340
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative flow cytometric determination of anthracycline content of rat bone marrow cells.
    Nooter K; van den Engh G; Sonneveld P
    Cancer Res; 1983 Nov; 43(11):5126-30. PubMed ID: 6616450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the enzyme activities of neutrophils in Wistar rats treated with 4-amino-pteroylglutamic acid and in their inbred offspring. 3. Hematologic and histologic observations.
    Ito S
    Naika Hokan; 1966 May; 13(5):269-78. PubMed ID: 6006125
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytogenetic examination of bone marrow cells and peripheral lymphocytes in rats exposed to cyclophosphamide.
    Topinková E; Srám RJ
    Folia Biol (Praha); 1982; 28(5):302-10. PubMed ID: 7173448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.